Cybin Inc. (NYSE AMERICAN: CYBN) Stock Information | RedChip

Cybin Inc. (NYSE AMERICAN: CYBN) Listen to this Section


$0.26
-0.0046 ( -1.74% ) 9.0M

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 3 May 29, 2024
6-k Quarterly Reports 3 May 14, 2024
6-k Quarterly Reports 3 May 06, 2024
6-k Quarterly Reports 3 Apr 25, 2024
6-k Quarterly Reports 4 Apr 18, 2024
6-k Quarterly Reports 3 Apr 18, 2024
6-k Quarterly Reports 3 Apr 16, 2024
6-k Quarterly Reports 3 Apr 10, 2024
6-k Quarterly Reports 2 Mar 22, 2024
6-k Quarterly Reports 2 Mar 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.